Thérèse Di Paolo

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Anatomy

Chemicals & Drugs

Living Beings

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tamim Mohamed Khalil; Samadi Pershia; Morissette Marc; Grégoire Laurent; Ouattara Bazoumana; Lévesque Daniel; Rouillard Claude; Di Paolo Thérèse
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Mahmoudi Souha; Samadi Pershia; Gilbert François; Ouattara Bazoumana; Morissette Marc; Grégoire Laurent; Rouillard Claude; Di Paolo Thérèse; Lévesque Daniel
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.
Bourque Mélanie; Dluzen Dean E; Di Paolo Thérèse
Neuroprotective actions of sex steroids in Parkinson's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Thérèse Di Paolo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Tamim Mohamed Khalil; Samadi Pershia; Morissette Marc; Grégoire Laurent; Ouattara Bazoumana; Lévesque Daniel; Rouillard Claude; Di Paolo Thérèse
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Neuropharmacology 2010;58(1):286-96.
2009: Mahmoudi Souha; Samadi Pershia; Gilbert François; Ouattara Bazoumana; Morissette Marc; Grégoire Laurent; Rouillard Claude; Di Paolo Thérèse; Lévesque Daniel
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.
Neurobiology of disease 2009;36(1):213-22.
2009: Bourque Mélanie; Dluzen Dean E; Di Paolo Thérèse
Neuroprotective actions of sex steroids in Parkinson's disease.
Frontiers in neuroendocrinology 2009;30(2):142-57.
2009: Grégoire Laurent; Samadi Pershia; Graham Julie; Bédard Paul J; Bartoszyk Gerd D; Di Paolo Thérèse
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
Parkinsonism & related disorders 2009;15(6):445-52.
2009: Ouattara Bazoumana; Belkhir Samah; Morissette Marc; Dridi Mehdi; Samadi Pershia; Grégoire Laurent; Meltzer Leonard T; Di Paolo Thérèse
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
Journal of molecular neuroscience : MN 2009;38(2):128-42.
2009: Morissette Marc; Di Paolo Thérèse
Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
Journal of neuroscience research 2009;87(7):1634-44.
2009: Samadi Pershia; Rajput Alex; Calon Frédéric; Grégoire Laurent; Hornykiewicz Oleh; Rajput Ali H; Di Paolo Thèrèse
Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
Journal of neuropathology and experimental neurology 2009;68(4):374-82.
2008: Morissette Marc; Al Sweidi Sara; Callier Sophie; Di Paolo Thérèse
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
Molecular and cellular endocrinology 2008;290(1-2):60-9.
2008: Morissette M; Le Saux M; Di Paolo T
Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors.
Journal of neuroendocrinology 2008;20(8):1006-14.
2008: Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Dridi Mehdi; Belanger Nancy; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Neurobiology of aging 2008;29(7):1040-51.
2008: Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Bélanger Nancy; Dridi Mehdi; Bédard Paul J; Di Paolo Thérèse
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
Neuropharmacology 2008;54(2):258-68.
2008: Samadi Pershia; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Dridi Mehdi; Belanger Nancy; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Synapse (New York, N.Y.) 2008;62(2):101-9.
2008: Morissette M; Le Saux M; D'Astous M; Jourdain S; Al Sweidi S; Morin N; Estrada-Camarena E; Mendez Pablo; Garcia-Segura Luis Miguel; Di Paolo T
Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.
The Journal of steroid biochemistry and molecular biology 2008;108(3-5):327-38.
2008: Grégoire Laurent; Rassoulpour Arash; Guidetti Paolo; Samadi Pershia; Bédard Paul J; Izzo Emanuela; Schwarcz Robert; Di Paolo Thérèse
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Behavioural brain research 2008;186(2):161-7.
2007: Bourque Mélanie; Liu Bin; Dluzen Dean E; Di Paolo Thérèse
Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
Biochemical pharmacology 2007;74(9):1413-23.
2007: Morissette Marc; Jourdain Sandra; Al Sweidi Sara; Menniti Frank S; Ramirez Andres D; Di Paolo Thérèse
Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.
Neuropharmacology 2007;52(7):1509-20.
2007: Samadi Pershia; Rouillard Claude; Bédard Paul J; Di Paolo Thérèse
Functional neurochemistry of the basal ganglia.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():19-66.
2006: Bélanger Nancy; Grégoire Laurent; Bédard Paul J; Di Paolo Thérèse
DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys.
Neurobiology of aging 2006;27(11):1684-93.
2006: Le Saux Maryvonne; Estrada-Camarena Erika; Di Paolo Thérèse
Selective estrogen receptor-alpha but not -beta agonist treatment modulates brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Journal of neuroscience research 2006;84(5):1076-84.
2006: Gilbert François; Morissette Marc; St-Hilaire Michel; Paquet Brigitte; Rouillard Claude; Di Paolo Thérèse; Lévesque Daniel
Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover.
Biological psychiatry 2006;60(6):538-47.
2006: Morissette Marc; Dridi Mehdi; Calon Frédéric; Hadj Tahar Abdallah; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Synapse (New York, N.Y.) 2006;60(3):239-50.
2006: Julien Carl; Berthiaume Line; Hadj-Tahar Abdallah; Rajput Ali H; Bédard Paul J; Di Paolo Thérèse; Julien Pierre; Calon Frédéric
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Neurochemistry international 2006;48(5):404-14.
2006: D'Astous Myreille; Mendez Pablo; Morissette Marc; Garcia-Segura Luis Miguel; Di Paolo Thérèse
Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Molecular pharmacology 2006;69(4):1492-8.
2006: Le Saux Maryvonne; Morissette Marc; Di Paolo Thérèse
ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens.
Neuropharmacology 2006;50(4):451-7.
2006: Samadi Pershia; Grégoire Laurent; Rouillard Claude; Bédard Paul J; Di Paolo Thérèse; Lévesque Daniel
Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Annals of neurology 2006;59(2):282-8.
2006: Le Saux M; Di Paolo T
Influence of oestrogenic compounds on monoamine transporters in rat striatum.
Journal of neuroendocrinology 2006;18(1):25-32.
2006: Morissette Marc; Dridi Mehdi; Calon Frédéric; Hadj Tahar Abdallah; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):9-17.
2005: Jourdain S; Morissette M; Morin N; Di Paolo T
Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Journal of neuroendocrinology 2005;17(8):509-17.
2005: Samadi Pershia; Grégoire Laurent; Hadj Tahar Abdallah; Di Paolo Thérèse; Rouillard Claude; Bédard Paul J
Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
Neuropharmacology 2005;49(2):165-73.
2005: Bordeleau Louis-Jean; Gailis Laimonis; Fournier Dominique; Morissette Marc; Di Paolo Thérèse; Daleau Pascal
Cut-off phenomenon in the protective effect of alcohols against lysophosphatidylcholine-induced calcium overload.
Pflügers Archiv : European journal of physiology 2005;450(5):292-7.
2005: D'Astous Myreille; Morissette Marc; Callier Sophie; Di Paolo Thérèse
Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
Journal of neuroscience research 2005;80(1):138-44.
2005: Le Saux Maryvonne; Di Paolo Thérèse
Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens.
Psychoneuroendocrinology 2005;30(3):251-60.
2005: Le Saux Maryvonne; Di Paolo Thérèse
Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Journal of psychiatry & neuroscience : JPN 2005;30(2):110-7.
2005: D'Astous Myreille; Mickley Katherine R; Dluzen Dean E; Di Paolo Thérèse
Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
Neuroendocrinology 2005;82(2):111-20.
2004: D'Astous Myreille; Morissette Marc; Di Paolo Thérèse
Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.
Neuropharmacology 2004;47(8):1180-8.
2004: Blanchet Pierre J; Calon Frédéric; Morissette Marc; Hadj Tahar Abdallah; Bélanger Nancy; Samadi Pershia; Grondin Richard; Grégoire Laurent; Meltzer Leonard; Di Paolo Thérèse; Bédard Paul J
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Parkinsonism & related disorders 2004;10(5):297-304.
2004: Rajput Ali H; Fenton Mark E; Di Paolo Thérèse; Sitte Harold; Pifl Christian; Hornykiewicz Oleh
Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off.
Parkinsonism & related disorders 2004;10(4):221-6.
2004: Calon Frédéric; Dridi Mehdi; Hornykiewicz Oleh; Bédard Paul J; Rajput Ali H; Di Paolo Thérèse
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Brain : a journal of neurology 2004;127(Pt 5):1075-84.
2004: D'Astous Myreille; Gajjar Tapasdip M; Dluzen Dean E; Di Paolo Thérèse
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
Neuroendocrinology 2004;79(6):296-304.
2003: Calon Frédéric; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Neurobiology of disease 2003;14(3):404-16.
2003: Bélanger Nancy; Grégoire Laurent; Bédard Paul; Di Paolo Thérèse
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Endocrine 2003;21(1):97-101.
2003: Landry Michelle; Di Paolo Thérèse
Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
Brain research. Molecular brain research 2003;112(1-2):82-9.
2003: Calon Frédéric; Morissette Marc; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):241-53.
2003: D'Astous Myreille; Morissette Marc; Tanguay Bastien; Callier Sophie; Di Paolo Thérèse
Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
Synapse (New York, N.Y.) 2003;47(1):10-4.
2003: Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard P J
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Advances in neurology 2003;91():51-64.
2002: Vaillancourt Cathy; Cyr Michel; Rochford Joseph; Boksa Patricia; Di Paolo Thérèse
Effects of ovariectomy and estradiol on acoustic startle responses in rats.
Pharmacology, biochemistry, and behavior 2002;74(1):103-9.
2002: Landry Michelle; Lévesque Daniel; Di Paolo Thérèse
Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
Neuroendocrinology 2002;76(4):214-22.
2002: Calon Frédéric; Di Paolo Thérèse
Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain.
Parkinsonism & related disorders 2002;8(6):449-54.
2002: Ekue A; Boulanger J-F; Morissette M; Di Paolo T
Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.
Journal of neuroendocrinology 2002;14(9):731-6.
2002: Calon Frédéric; Birdi Sam; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Journal of neuropathology and experimental neurology 2002;61(2):186-96.
2002: Callier Sophie; Le Saux Maryvonne; Lhiaubet Anne-Marie; Di Paolo Thérèse; Rostène William; Pelaprat Didier
Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Journal of neurochemistry 2002;80(2):307-16.
2002: Calon Frédéric; Morissette Marc; Ghribi Othman; Goulet Martin; Grondin Richard; Blanchet Pierre J; Bédard Paul J; Di Paolo Thérèse
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):127-38.
2002: Cyr Michel; Calon Frederic; Morissette Marc; Di Paolo Thérèse
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.
Journal of psychiatry & neuroscience : JPN 2002;27(1):12-27.
2001: Cyr M; Ghribi O; Thibault C; Morissette M; Landry M; Di Paolo T
Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors.
Brain research. Brain research reviews 2001;37(1-3):153-61.
2001: Tekumalla P K; Calon F; Rahman Z; Birdi S; Rajput A H; Hornykiewicz O; Di Paolo T; Bédard P J; Nestler E J
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biological psychiatry 2001;50(10):813-6.
2001: Cyr M; Thibault C; Morissette M; Landry M; Di Paolo T
Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(2):242-57.
2001: Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
Synapse (New York, N.Y.) 2001;41(2):131-8.
2001: Calon F; Lavertu N; Lemieux A M; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Synapse (New York, N.Y.) 2001;40(3):225-34.
2001: Cyr M; Morissette M; Landry M; Di Paolo T
Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.
Neuroreport 2001;12(3):535-9.
2001: Cyr M; Charbonneau C; Morissette M; Rochford J; Barden N; Di Paolo T
Central 5-hydroxytryptamine-2A receptor expression in transgenic mice bearing a glucocorticoid receptor antisense.
Neuroendocrinology 2001;73(1):37-45.
2001: Blanchet P J; Calon F; Morissette M; Goulet M; Grondin R; Lévesque D; Bédard P J; Di Paolo T
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Advances in neurology 2001;86():337-44.
2001: Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Neuroscience 2001;102(1):151-8.
2000: Calon F; Hadj Tahar A; Blanchet P J; Morissette M; Grondin R; Goulet M; Doucet J P; Robertson G S; Nestler E; Di Paolo T; Bédard P J
Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
Trends in neurosciences 2000;23(10 Suppl):S92-100.
2000: Callier S; Morissette M; Grandbois M; Di Paolo T
Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
Synapse (New York, N.Y.) 2000;37(4):245-51.
2000: Cyr M; Calon F; Morissette M; Grandbois M; Di Paolo T; Callier S
Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.
Current pharmaceutical design 2000;6(12):1287-312.
2000: Cyr M; Landry M; Di Paolo T
Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(1):69-78.
2000: Goulet M; Grondin R; Morissette M; Maltais S; Falardeau P; Bédard P J; Di Paolo T
Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(4):607-17.
2000: Cyr M; Ghribi O; Di Paolo T
Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain.
Journal of neuroendocrinology 2000;12(5):445-52.
2000: Calon F; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
Experimental neurology 2000;163(1):191-9.
2000: Calon F; Grondin R; Morissette M; Goulet M; Blanchet P J; Di Paolo T; Bédard P J
Molecular basis of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S70-8.
2000: Grandbois M; Morissette M; Callier S; Di Paolo T
Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice.
Neuroreport 2000;11(2):343-6.
1999: Morissette M; Dicko A; Pézolet M; Callier S; Di Paolo T
Effect of dehydroepiandrosterone and its sulfate and fatty acid ester derivatives on rat brain membranes.
Steroids 1999;64(11):796-803.
1999: Grondin R; Goulet M; Morissette M; Bédard P J; Di Paolo T
Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
European journal of pharmacology 1999;378(3):259-63.
1999: Dicko A; Morissette M; Ben Ameur S; Pézolet M; Di Paolo T
Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy.
Brain research bulletin 1999;49(6):401-5.
1999: Calon F; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content.
Neurochemistry international 1999;35(1):81-91.
1999: Goulet M; Morissette M; Grondin R; Falardeau P; Bédard P J; Rostène W; Di Paolo T
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Synapse (New York, N.Y.) 1999;32(3):153-64.
1999: Morissette M; Grondin R; Goulet M; Bédard P J; Di Paolo T
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Journal of neurochemistry 1999;72(2):682-92.
1998: Morissette M; Goulet M; Grondin R; Blanchet P; Bédard P J; Di Paolo T; Lévesque D
Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
The European journal of neuroscience 1998;10(8):2565-73.
1998: Dicko A; Di Paolo T; Pézolet M
Interaction of dehydroepiandrosterone with phospholipid membranes: an infrared spectroscopy investigation.
Biochimica et biophysica acta 1998;1368(2):321-8.
1997: Morissette M; Goulet M; Soghomonian J J; Blanchet P J; Calon F; Bédard P J; Di Paolo T
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Brain research. Molecular brain research 1997;49(1-2):55-62.
1997: Carli M; Morissette M; Hébert C; Di Paolo T; Reader T A
Effects of a chronic lithium treatment on central dopamine neurotransporters.
Biochemical pharmacology 1997;54(3):391-7.
1997: Goulet M; Morissette M; Calon F; Blanchet P J; Falardeau P; Bédard P J; Di Paolo T
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
Neuroscience 1997;79(2):497-507.
1997: Bossé R; Rivest R; Di Paolo T
Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain.
Brain research. Molecular brain research 1997;46(1-2):343-6.
1996: Morissette M; Goulet M; Calon F; Falardeau P; Blanchet P J; Bédard P J; Di Paolo T
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Molecular pharmacology 1996;50(5):1073-9.
1996: Grondin R; Goulet M; Di Paolo T; Bédard P J
Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.
Brain research 1996;735(2):298-306.
1996: Soghomonian J J; Pedneault S; Blanchet P J; Goulet M; Di Paolo T; Bédard P J
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys.
Brain research. Molecular brain research 1996;39(1-2):237-40.
1996: Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.
Brain research 1996;719(1-2):129-37.
1995: Rivest R; Falardeau P; Di Paolo T
Brain dopamine transporter: gender differences and effect of chronic haloperidol.
Brain research 1995;692(1-2):269-72.
1995: Gagnon C; Gomez-Mancilla B; Markstein R; Bédard P J; Di Paolo T
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(4):667-76.
1995: Calon F; Goulet M; Blanchet P J; Martel J C; Piercey M F; Bédard P J; Di Paolo T
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Brain research 1995;680(1-2):43-52.
1995: Petitclerc M; Bédard P J; Di Paolo T
Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(3):491-7.
1995: Blanchet P J; Calon F; Martel J C; Bédard P J; Di Paolo T; Walters R R; Piercey M F
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):854-9.
1995: Blanchet P J; Gomez-Mancilla B; Di Paolo T; Bédard P J
Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?
Fundamental & clinical pharmacology 1995;9(5):434-42.
1994: Di Paolo T
Modulation of brain dopamine transmission by sex steroids.
Reviews in the neurosciences 1994;5(1):27-41.
1993: Gagnon C; Gomez-Mancilla B; Bédard P J; Di Paolo T
Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.
Neuroscience letters 1993;163(1):31-5.
1993: Rioux L; Gagnon C; Gaudin D P; Di Paolo T; Bédard P J
A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors.
Neuroscience 1993;56(1):45-51.
1993: Morissette M; Di Paolo T
Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.
Journal of neurochemistry 1993;60(5):1876-83.
1993: Gomez-Mancilla B; Boucher R; Gagnon C; Di Paolo T; Markstein R; Bédard P J
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):144-50.
1993: Gagnon C; Bédard P J; Di Paolo T
Grafts in the treatment of Parkinson's disease: animal models.
Reviews in the neurosciences 1993;4(1):17-40.
1992: Morissette M; Lévesque D; Di Paolo T
Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
Molecular pharmacology 1992;42(3):480-8.
1992: Morissette M; Garcia-Segura L M; Bélanger A; Di Paolo T
Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle.
Neuroscience 1992;49(4):893-902.
1992: Biron D; Dauphin C; Di Paolo T
Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors.
Neuroendocrinology 1992;55(4):468-76.
1991: Gagnon C; Bédard P J; Rioux L; Gaudin D; Martinoli M G; Pelletier G; Di Paolo T
Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Brain research 1991;558(2):251-63.
1991: Lévesque D; Di Paolo T
Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Molecular pharmacology 1991;39(5):659-65.
1991: Rioux L; Gaudin D P; Gagnon C; Di Paolo T; Bédard P J
Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
Neuroscience 1991;44(1):75-83.
1990: Morissette M; Lévesque D; Bélanger A; Di Paolo T
A physiological dose of estradiol with progesterone affects striatum biogenic amines.
Canadian journal of physiology and pharmacology 1990;68(12):1520-6.
1990: Morissette M; Biron D; Di Paolo T
Effect of estradiol and progesterone on rat striatal dopamine uptake sites.
Brain research bulletin 1990;25(3):419-22.
1990: Rouillard C; Bédard P J; Di Paolo T
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
European journal of pharmacology 1990;185(2-3):209-15.
1990: Gagnon C; Bédard P J; Di Paolo T
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
European journal of pharmacology 1990;178(1):115-20.
1990: Lévesque D; Di Paolo T
Effect of the rat estrous cycle at ovariectomy on striatal D-1 dopamine receptors.
Brain research bulletin 1990;24(2):281-4.
1989: Di Paolo T; Rouillard C; Morissette M; Lévesque D; Bédard P J
Endocrine and neurochemical actions of cocaine.
Canadian journal of physiology and pharmacology 1989;67(9):1177-81.
1989: Lévesque D; Gagnon S; Di Paolo T
Striatal D1 dopamine receptor density fluctuates during the rat estrous cycle.
Neuroscience letters 1989;98(3):345-50.
1989: Di Paolo T; Bédard F; Bédard P J
Influence of gonadal steroids on human and monkey cerebrospinal fluid homovanillic acid concentrations.
Clinical neuropharmacology 1989;12(1):60-6.
1989: Lévesque D; Di Paolo T
Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
Life sciences 1989;45(19):1813-20.
1988: Rouillard C; Bédard P; Falardeau P; Di Paolo T
Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
European journal of pharmacology 1988;157(2-3):125-33.
1988: Di Paolo T; Bernier M A
Estradiol and guanine nucleotide modulation of dopamine receptor agonist and antagonist binding sites in 7315a pituitary tumors.
Biochemical pharmacology 1988;37(12):2373-9.
1988: Falardeau P; Bouchard S; Bédard P J; Boucher R; Di Paolo T
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
European journal of pharmacology 1988;150(1-2):59-66.
1988: Lévesque D; Di Paolo T
Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol.
Neuroscience letters 1988;88(1):113-8.
1988: Di Paolo T; Lévesque D
Sodium and guanine nucleotide regulation of dopamine receptor agonist and antagonist binding sites in MtTW15 pituitary tumors.
Canadian journal of physiology and pharmacology 1988;66(3):246-9.
1988: Falardeau P; Bédard P J; Di Paolo T
Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
Neuroscience letters 1988;86(2):225-9.
1988: Di Paolo T; Falardeau P; Morissette M
Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle.
Life sciences 1988;43(8):665-72.
1985: Di Paolo T; Rouillard C; Bédard P
17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.
European journal of pharmacology 1985;117(2):197-203.
1984: Deshaies P; Bédard P; Falardeau P; Di Paolo T
Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors.
Neuropharmacology 1984;23(10):1219-22.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Thérèse Di Paolo

Research Profile (preview)

Procedures

Anatomy

Chemicals & Drugs

Living Beings

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Thérèse Di Paolo (preview)

All Publications